首页> 外文期刊>Phytomedicine : >Quality control and producing areas differentiation of Gardeniae Fructus for eight bioactive constituents by HPLC-DAD-ESI/MS
【24h】

Quality control and producing areas differentiation of Gardeniae Fructus for eight bioactive constituents by HPLC-DAD-ESI/MS

机译:HPLC-DAD-ESI / MS对Garden子中8种生物活性成分的质量控制和产地区分

获取原文
获取原文并翻译 | 示例
           

摘要

Gardeniae Fructus (G.Fructus), the fruit of Gardenia jasminoides Ellis (Rubiaceae), is a commonly used traditional Chinese medicine (TCM) that has been used for the treatment of hepatitis, jaundice, hypersonic, diabetes and hematuria. Numerous researches have demonstrated that the major active constituents in G.Fructus were responsible for the majority of medical effects of this fruit and their quantification were important for the quality control of G.Fructus. However, in the current quality control standard, only geniposide was used as characteristic marker of G.Fructus, which could not reflect the overall quality of this fruit. In order to identify more chemical makers for improving the quality control standard and evaluate producing areas differentiation of G.Fructus, in the present study, a novel and sensitive high-performance liquid chromatography-diode array detector coupled to an electrospray tandem mass spectrometer (HPLC-DAD-ESI/MS) was developed for the simultaneous determination of 8 major constituents, including geniposidic acid (1), chlorogenic acid (2), genipin-1-β-gentiobioside (3), geniposide (4), genipin (5), rutin (6), crocin-1 (7), crocin-2 (8) in G.Fructus. Moreover, chemometric analysis techniques with principal component constituent analysis (PCA) and cluster analysis (CA) involved were introduced in statistical analysis of 8 investigated constituents in the 34 batches samples to discriminate the samples from different producing areas. The results indicated that the contents of the 8 major bioactive constituents in G.Fructus varied significantly among different producing areas. From results of the loading plot from PCA analysis, genipin-1-β-gentiobioside may have more influence in discriminating the sample from different producing areas, and which was found to be the most abundant bioactive component besides geniposide in all the 34 batches samples, suggesting that it should be added as chemical marker for further investigation on the pharmacological actions and the quality control of G.Fructus.
机译:ia子(,子)的果实是子(G.Fructus),是一种常用的中药(TCM),已被用于治疗肝炎,黄疸,高超声速,糖尿病和血尿。大量研究表明,G.Fructus的主要活性成分是该果实的大部分医学功效,它们的定量对于G.Fructus的质量控制很重要。然而,在当前的质量控制标准中,仅子苷被用作G.Fructus的特征标记,不能反映该水果的整体质量。为了确定更多的化学制造商以提高质量控制标准并评估G.Fructus的产地差异,在本研究中,将新颖,灵敏的高效液相色谱-二极管阵列检测器与电喷雾串联质谱仪(HPLC)结合使用-DAD-ESI / MS)用于同时测定8种主要成分,包括Geniposidic acid(1),绿原酸(2),genipin-1-β-gentiobioside(3),geniposide(4),genipin(5) ),G.Fructus中的芦丁(6),crocin-1(7),crocin-2(8)。此外,在涉及34批次样品的8种被调查成分的统计分析中,引入了涉及主成分分析(PCA)和聚类分析(CA)的化学计量分析技术,以区分来自不同产地的样品。结果表明,不同产地的山茱G中8种主要生物活性成分的含量差异很大。从PCA分析的负载图结果来看,genipin-1-β-龙胆总糖苷可能在区分不同产地的样品中具有更大的影响力,并且发现在所有34批次样品中,genipin-1-β-龙胆总糖苷是除gen子苷之外最丰富的生物活性成分,建议添加它作为化学标记,以进一步研究山茱G的药理作用和质量控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号